Desk› Healthcare› Brawn Biotech Ltd
Brawn Biotech Ltd
Filing rhythm · 60 trading days
6 filings · 2 material · busiest 2026-08-13
What it files
Filings
6 in the window
-
14 August 2026
Newspaper PublicationNewspaper Publication
Publication of Un-audited financial results for the quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
13 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended June 30, 2026.
Outcome of Board Meeting held on August 13, 2026 to consider and approve, inter-alia, un-audited financial results of the company for quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026
ResultsOutcome Of Board Meeting Held On August 13, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended June 30, 2026.
Outcome of Board Meeting held on August 13, 2026 to consider and approve, inter-alia, un-audited financial results of the company for quarter ended June 30, 2026.
Result / Financial Results View filing →
-
5 August 2026
Board MeetingBoard Meeting Intimation for Consideration And Approval Of, Inter Alia, The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Brawn Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
Board Meeting / Board Meeting View filing →
-
8 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5)
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 June 2026
Trading WindowClosure of Trading Window
Closure of Trading Window for the quarter ended June 30, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →